EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients

Tianqi Zhang iD, Qiao Zhang, Xinwei He iD, Yuting Lu, Andrew Shao, Xiaoqiang Sun, Yongzhao Shao iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25053076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tianqi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, New York University Grossman School of Medicine, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Radiation Oncology, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIOSH CDC HHS, US National Cancer Institute (NCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent mechanistic studies have indicated that combinations of radiotherapy (RT) plus immunotherapy (via CSF-1R inhibition) can serve as a strategy to overcome RT resistance and improve the survival of glioma mice. Given the high mortality rate for glioma, including low-grade glioma (LGG) patients, it is of critical importance to investigate the mechanism of the combination of RT and immunotherapy and further translate the mechanism from mouse studies to improve survival of RT-treated human glioma patients. Using the RNA-seq data from a glioma mouse study, 874 differentially expressed genes (DEGs) between the group of RT-treated mice at glioma recurrence and the group of mice with combination treatment (RT plus CSF-1R inhibition) were translated to the human genome to identify significant molecular pathways using the KEGG enrichment analysis. The enrichment analysis yields statistically significant signaling pathways, including the phosphoinositide 3-kinase (PI3K)/AKT pathway, Hippo pathway, and Notch pathway. Within each pathway, a candidate gene set was selected by Cox regression models as genetic biomarkers for resistance to RT and response to the combination of RT plus immunotherapies. Each Cox model is trained using a cohort of 295 RT-treated LGG patients from The Cancer Genome Atlas (TCGA) database and validated using a cohort of 127 RT-treated LGG patients from the Chinese Glioma Genome Atlas (CGGA) database. A four-DEG signature (ITGB8, COL9A3, TGFB2, JAG1) was identified from the significant genes within the three pathways and yielded the area under time-dependent ROC curve AUC = 0.86 for 5-year survival in the validation set, which indicates that the selected DEGs have strong prognostic value and are potential intervention targets for combination therapies. These findings may facilitate future trial designs for developing combination therapies for glioma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation OncologyGliomaBrain NeoplasmsHumansAnimalsMicePhosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinaseImmunotherapy

Stichwörter der Autor:innen

CSF-1Rimmunotherapyradiation therapytranslational research strategytumor microenvironmenttumor-associated macrophage cells

Substanzen

Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • Department of Population Health, New York University Grossman School of Medicine, New York, NY 10016, USA.
  • School of Mathematics, Sun Yat-sen University, Guangzhou 510275, China.
  • Center of Data Science, New York University, New York, NY 10011, USA.

ORCID-Profile: Tianqi Zhang, Xinwei He, Yongzhao Shao

Förderung

  • NCI NIH HHS
  • NIOSH CDC HHS
  • US National Cancer Institute (NCI)
  • Centers for Disease Control and Prevention
  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Guangzhou Basic and Applied Basic Research Project

Zitieren

APA

Zhang, T., Zhang, Q., He, X., Lu, Y., Shao, A., Sun, X., & Shao, Y. (2024). Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053076

Vancouver

Zhang T, Zhang Q, He X, Lu Y, Shao A, Sun X, et al. Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053076

BibTeX
@article{Zhang2024,
  author = {Zhang, Tianqi and Zhang, Qiao and He, Xinwei and Lu, Yuting and Shao, Andrew and Sun, Xiaoqiang and Shao, Yongzhao},
  title = {Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25053076}
}
Kostenlos starten →